Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: J Card Fail. 2021 Aug;27(8):915–919. doi: 10.1016/j.cardfail.2021.02.016

Table:

Demographics and outcomes for subjects with and without HF

Heart failure (N=131) No heart failure (N=392)
Age (years) 68 (9.4) 68.4 (9.1)
Male sex 95 (72.5) 301 (76.8)
Prior MI 47 (35.9) 51 (13.0)
Hypertension 104 (79.4) 287 (73.2)
Diabetes 55 (42.0) 106 (27.0)
Sleep apnea 19 (14.5) 44 (11.2)
Body-mass index 29.1 (5.6) 28.7 (5.1)
Pre-operative medical therapy
Beta blocker 98 (74.8) 209 (53.3)
ACE or ARB 73 (55.7) 196 (50.0)
Calcium channel blocker 26 (19.9) 84 (21.4)
Preoperative LVEF (%) 45.1 (13.3) 60.3 (5.6)
Procedure
CABG 65 (49.6) 147 (37.5)
Valve repair 15 (11.5) 67 (17.1)
CABG + valve repair 6 (4.6) 11 (2.8)
Valve replacement 20 (15.2) 106 (27.0)
CABG + valve replacement 25 (19.1) 61 (15.6)
CABG only (%) 65 (49.6) 147 (37.5)
Cardiopulmonary bypass time 122.2 (50.0) 99.3 (40.0)
Rhythm control strategy 64 (48.9) 197 (50.3)
Cross-over to alternate strategy (%) 37 (28.2) 95 (24.2)
ICU length of stay (days) 3.9 (5.5) 2.6 (3.8)
Readmission 30 (22.9) 96 (24.5)
Death 2 (1.5) 3 (0.8)
Days alive and out of hospital (days) 51.0 (12.0) 52.1 (13.2)
Sinus rhythm at 7 days 104 (82.5) 318 (83.9)
Sinus rhythm at 30 days 114 (93.4) 348 (94.2)
Sinus rhythm at 60 days 112 (94.1) 348 (96.9)
AF for less than 48 hours 75 (57.3) 231 (58.9)

Heart failure (N=131) Rate control Rhythm control
Age (years) 68.0 (11.05) 67.9 (7.3)
Male sex 52 (77.6) 43 (67.2)
Prior MI 26 (38.8) 21 (32.8)
Hypertension 53 (79.1) 51 (79.7)
Diabetes 28 (41.8) 27 (42.2)
Sleep apnea 10 (14.9) 9 (14.1)
Body-mass index 29.2 (5.3) 29.1 (5.9)
Pre-operative medical therapy
Beta blocker 52 (77.6) 46 (71.9)
ACE or ARB 37 (55.2) 36 (56.3)
Calcium channel blocker 10 (14.9) 16 (25.0)
Preoperative LVEF (%) 44.3 (13.9) 46.0 (12.6)
Procedure
CABG 36 (53.7) 29 (45.3)
Valve repair 8 (11.9) 7 (10.9)
CABG + valve repair 5 (7.5) 1 (1.6)
Valve replacement 9 (13.4) 11 (17.2)
CABG + valve replacement 9 (13.4) 16 (25.0)
CABG only (%) 36 (53.7) 29 (45.3)
Cardiopulmonary bypass time 122.5 (50.4) 121.9 (50.0)
Off-pump procedure 3 (4.5) 4 (6.3)
Cross-over to alternate strategy (%) 17 (25.4) 20 (31.3)
Readmission 16 (23.9) 14 (21.9)
Death 1 (1.5) 1 (1.6)
Days alive and out of hospital (days) 51.1 (11.4) 50.8 (12.7)
Sinus rhythm at 7 days 50 (76.9) 54 (88.5)
Sinus rhythm at 30 days 57 (91.9) 57 (95.0)
Sinus rhythm at 60 days 56 (90.3) 56 (98.3)
AF for less than 48 hours 31 (46.3) 44 (68.8)

No heart failure (N=392) Rate control Rhythm control
Age (years) 68.9 (9.4) 67.9 (8.8)
Male sex 145 (74.4) 156 (79.2)
Prior MI 24 (12.3) 27 (13.7)
Hypertension 140 (71.8) 147 (74.6)
Diabetes 54 (27.7) 52 (26.4)
Sleep apnea 23 (11.8) 21 (10.7)
Body-mass index 28.1 (4.8) 29.2 (5.4)
Pre-operative medical therapy
Beta blocker 110 (56.4) 99 (50.3)
ACE or ARB 102 (52.3) 94 (47.7)
Calcium channel blocker 42 (21.5) 42 (21.3)
Preoperative LVEF (%) 61.0 (6.04) 59.6 (5.06)
Procedure
CABG 76 (39.0) 71 (36.0)
Valve repair 31 (15.9) 36 (18.3)
CABG + valve repair 5 (2.6) 6 (3.1)
Valve replacement 51 (26.2) 55 (27.9)
CABG + valve replacement 32 (16.4) 29 (14.7)
CABG only (%) 76 (39.0) 71 (36.0)
Cardiopulmonary bypass time 97.6 (39.9) 101.04 (40.1)
Off-pump procedure 3 (1.5) 8 (4.1)
Cross-over to alternate strategy (%) 53 (27.2) 42 (21.3)
Readmission 46 (23.6) 50 (25.4)
Death 2 (1.03) 1 (0.5)
Days alive and out of hospital (days) 51.3 (13.0) 52.8 (13.4)
Sinus rhythm at 7 days 153 (80.5) 165 (87.3)
Sinus rhythm at 30 days 170 (94.4) 178 (95.2)
Sinus rhythm at 60 days 170 (94.4) 178 (95.2)
AF for less than 48 hours 106 (54.4) 125 (63.5)